If your formulation arrives as a lyophilized powder requiring reconstitution, that guide covers the exact process including how much bacteriostatic water to use
This medication acts by replicating the hormone glucagon-like peptide-1 (GLP-1), which is crucial for appetite control and blood sugar regulation, making it a powerful tool in weight management
However, berberine is not a GLP-1 receptor agonist and does not bind to or activate GLP-1 receptors
The FDA determined the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in February 2025, and it set enforcement deadlines through 2025 for compounders to wind down shortage-based production
Initially, some users may experience fatigue, but this often improves as the body adjusts to the medication
The evidence base for GLP-1 receptor agonists specifically treating binge eating disorder (BED) remains limited but emerging